Theragene Pharmaceuticals Company

Theragene Pharmaceuticals combines innovative science and efficiency to develop life-saving therapies for many debilitating diseases.
Technology:
Cancer
Headquarters:
San Diego, California, United States
Funding Status:
Early Stage Venture
Founded Date:
2011
Last Funding Type:
Convertible Note
Investors Number:
1
Last Funding Date:
2017
Estimated Revenue:
$1M to $10M
Employee Number:
1-10
Total Funding:
548000
Industry:
Biotechnology, Pharmaceutical, Therapeutics
Investor Type:
Early Stage Venture